The Pharmaceutical industry is on the cusp of a major transition. Whilst the global population and energy demand grow there will continue to be a demand for Pharmaceutical and their related products. However, the industry must now also contend with the challenge of achieving net zero emissions by 2050. Transitioning businesses through production, cessation, decommissioning and the energy transition is now the new normal.
We continue to study industry trends and issues closely, so that we can better understand the challenges that our clients face, and how we can best help them to achieve success. In the Canadian, our Pharmaceutical centres of excellence in Canada are working closely with other network firms on delivering professional services to companies of all sizes.
Our business interests generate economic impacts at multiple levels across Canada. economy and in many different ways, from capital investments, taxes, jobs, production and technology development, to supporting a world class supply chain and the global procurement of Pharmaceutical Products.
CONTACT US